Skip to content
ORPHELIA Pharma
  • About us
  • Therapeutic Areas
    • Pipeline
    • Neurology
    • Oncology
  • Partners
  • News
  • Contact
×
  • About us
  • Therapeutic Areas
    • Pipeline
    • Neurology
    • Oncology
  • Partners
  • News
  • Contact
ORPHELIA Pharma

    Hear from us

    18 April 2023

    ORPHELIA Pharma selects Tanner Pharma to Initiate Named Patient Program for KIMOZO®

    Read More >
    2 March 2023

    ORPHELIA Pharma announces completion of patient recruitment for the TEMOkids clinical trial

    Read More >
    3 October 2022

    Event : BIO-EUROPE 2022 (Oct. 24-26, Leipzig, Germany)

    Read More >
    30 September 2022

    Publication: dispensing temozolomide using KIMOZO or Temodal capsules mixed with food

    Read More >
    23 September 2022

    SIOP 2022, Barcelona, Spain : September 28-October 1, 2022

    Read More >
    21 September 2022

    Event : European Paediatric Formulation Initiative – EuPFI  (Sept. 20-22, Rome, Italy)

    Read More >

    ORPHELIA Pharma
    85 boulevard Saint Michel
    75005 Paris – France
    Tel : +33 1 42 77 08 18
    Contact us

    • Politique de confidentialité
    • Data privacy policy
    ×
    • Politique de confidentialité
    • Data privacy policy